Notice of a Safety Symposium Sponsored by the NIH Recombinant DNA Advisory Committee (RAC) and the Intragovernmental Select Agent and Toxin Technical Advisory Committee (ISATTAC), 67191 [E8-26886]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 220 / Thursday, November 13, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Background information may be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov.
National Institutes of Health, Office of
the Director, Office of Biotechnology
Activities
Dated: November 5, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8–26886 Filed 11–12–08; 8:45 am]
Notice of a Safety Symposium
Sponsored by the NIH Recombinant
DNA Advisory Committee (RAC) and
the Intragovernmental Select Agent
and Toxin Technical Advisory
Committee (ISATTAC)
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
mstockstill on PROD1PC66 with NOTICES
There will be a safety symposium
entitled ‘‘Public Health and Biosafety
Practices for Research with 1918 H1N1
Influenza Virus’’ on December 2, 2008
co-sponsored by the RAC, a federal
advisory committee to the NIH Director
and the ISATTAC, an intragovernmental
committee that advises on Select Agent
issues including restricted experiments.
The meeting will be open to the public,
with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting. For further
information concerning this meeting
contact Ms. Lisa A. Parker, Advisory
Committee Coordinator, Office of
Biotechnology Activities, Office of the
Director, National Institutes of Health,
6705 Rockledge Drive, Room 750,
Bethesda, MD 20892–7985, 301–496–
9838, parkerla@od.nih.gov.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: December 2, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: The safety symposium will bring
together experts to provide their perspectives
on the safety, efficacy, and advisability of
pre-exposure antiviral prophylaxis for
researchers working with the reconstructed
pandemic 1918 H1N1 Influenza Virus and
how the presence or absence of pre-exposure
prophylaxis should be factored into a
determination of the appropriate
biocontainment level for work with the 1918
H1N1 Influenza Virus. Please check the
meeting agenda at http:www4.od.nih.gov/
oba/RAC/meeting.htm for more information.
Place: Fishers Lane Conference Center,
5635 Fishers Lane, Terrace Level, Rockville,
MD 20892.
Contact Person: Lisa A. Parker, Advisory
Committee Coordinator, Office of Science
Policy, Office of Biotechnology Activities,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750–A1, Bethesda, MD 20892,
301–496–9838, parkerla@mail.nih.gov.
Any interested person may file written
comments with the panel by forwarding the
statement to the contact person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
VerDate Aug<31>2005
17:13 Nov 12, 2008
Jkt 217001
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Form I–566, Extension of a
Currently Approved Information
Collection; Comment Request
30-Day Notice of Information
Collection Under Review: Form I–566,
Interagency Record of Individual
Requesting Change/Adjustment To or
From A or G Status or Requesting A, G,
or NATO Dependent Employment
Authorization; OMB Control Number
1615–0027.
ACTION:
The Department of Homeland
Security, U.S. Citizenship and
Immigration Services (USCIS) has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection was
previously published in the Federal
Register on August 15, 2008, at 73 FR
47961, allowing for a 60-day public
comment period. USCIS did not receive
any comments for this information
collection.
The purpose of this notice is to allow
an additional 30 days for public
comments. Comments are encouraged
and will be accepted until December 15,
2008. This process is conducted in
accordance with 5 CFR 1320.10.
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burden and associated
response time, should be directed to the
Department of Homeland Security
(DHS), and to the Office of Information
and Regulatory Affairs, Office of
Management and Budget (OMB), USCIS
Desk Officer. Comments may be
submitted to: USCIS, Chief, Regulatory
Management Division, Clearance Office,
111 Massachusetts Avenue, Suite 3008,
Washington, DC 20529. Comments may
also be submitted to DHS via facsimile
to 202–272–8352 or via e-mail at
rfs.regs@dhs.gov, and to the OMB USCIS
Desk Officer via facsimile at 202–395–
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
67191
6974 or via e-mail at
oira_submission@omb.eop.gov.
When submitting comments by e-mail
please make sure to add OMB Control
Number 1615–0027 in the subject box.
Written comments and suggestions from
the public and affected agencies should
address one or more of the following
four points:
(1) Evaluate whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
collection of information, including the
validity of the methodology and
assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques, or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of an existing information
collection.
(2) Title of the Form/Collection:
Interagency Record of Individual
Requesting Change/Adjustment To or
From A or G Status or Requesting A, G,
or NATO Dependent Employment.
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: Form I–566.
U.S. Citizenship and Immigration
Services.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals and
households. This information collection
facilitates processing of applications for
benefits filed by dependents of
diplomats, international organizations,
and NATO personnel by U.S.
Citizenship and Immigration Services,
and the Department of State.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 5,800 responses at 15 minutes
(.250 hours) per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: 1,450 annual burden hours.
If you have additional comments,
suggestions, or need a copy of the
information collection instrument,
E:\FR\FM\13NON1.SGM
13NON1
]]>Agencies
[Federal Register Volume 73, Number 220 (Thursday, November 13, 2008)]
[Notices]
[Page 67191]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26886]
[[Page 67191]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health, Office of the Director, Office of
Biotechnology Activities
Notice of a Safety Symposium Sponsored by the NIH Recombinant DNA
Advisory Committee (RAC) and the Intragovernmental Select Agent and
Toxin Technical Advisory Committee (ISATTAC)
There will be a safety symposium entitled ``Public Health and
Biosafety Practices for Research with 1918 H1N1 Influenza Virus'' on
December 2, 2008 co-sponsored by the RAC, a federal advisory committee
to the NIH Director and the ISATTAC, an intragovernmental committee
that advises on Select Agent issues including restricted experiments.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the contact person listed below in
advance of the meeting. For further information concerning this meeting
contact Ms. Lisa A. Parker, Advisory Committee Coordinator, Office of
Biotechnology Activities, Office of the Director, National Institutes
of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985,
301-496-9838, parkerla@od.nih.gov.
Name of Committee: Recombinant DNA Advisory Committee.
Date: December 2, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: The safety symposium will bring together experts to
provide their perspectives on the safety, efficacy, and advisability
of pre-exposure antiviral prophylaxis for researchers working with
the reconstructed pandemic 1918 H1N1 Influenza Virus and how the
presence or absence of pre-exposure prophylaxis should be factored
into a determination of the appropriate biocontainment level for
work with the 1918 H1N1 Influenza Virus. Please check the meeting
agenda at http:www4.od.nih.gov/oba/RAC/meeting.htm for more
information.
Place: Fishers Lane Conference Center, 5635 Fishers Lane,
Terrace Level, Rockville, MD 20892.
Contact Person: Lisa A. Parker, Advisory Committee Coordinator,
Office of Science Policy, Office of Biotechnology Activities,
National Institutes of Health, 6705 Rockledge Drive, Suite 750-A1,
Bethesda, MD 20892, 301-496-9838, parkerla@mail.nih.gov.
Any interested person may file written comments with the panel
by forwarding the statement to the contact person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation
of the interested person. Background information may be obtained by
contacting NIH OBA by e-mail oba@od.nih.gov.
Dated: November 5, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8-26886 Filed 11-12-08; 8:45 am]
BILLING CODE 4140-01-P
